Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181353 | PMC |
| http://dx.doi.org/10.14740/jocmr4914 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
COVID-19-Related Cholangiopathy: Histological Findings.
Diagnostics (Basel)
August 2024
School of Medicine of Bahia, Federal University of Bahia, Salvador 40026-010, Brazil.
Unlabelled: Cholangiopathy has been described in survivors of severe COVID-19, presenting significant clinical parallels to the pre-pandemic condition of secondary sclerosing cholangitis in critically ill patients (SSC-CIP). We aimed to examine the liver histopathology of individuals with persistent cholestasis after severe COVID-19.
Methods: We subjected post-COVID-19 cholestasis liver samples to routine staining techniques and cytokeratin 7 immunostaining and semi-quantitatively analyzed the portal and parenchymal changes.
Post-COVID-19 Cholangiopathy: Clinical and Radiologic Findings.
Korean J Radiol
November 2023
Department of Radiology, Asan Medical Center, Seoul, Republic of Korea.
Endoscopic Features of Post-COVID-19 Cholangiopathy and Its Management Using ERCP.
Am J Gastroenterol
April 2024
Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Introduction: Despite growing awareness of post-coronavirus disease 2019 (COVID-19) cholangiopathy as one of the most serious long-term gastrointestinal consequences of COVID-19, the endoscopic features of this disease are still poorly characterized. This study aimed to more precisely define its endoscopic features and to outline the role of endoscopic retrograde cholangiopancreatography (ERCP) in the management of this entity.
Methods: In this observational study, 46 patients with confirmed post-COVID-19 cholangiopathy were included.
Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention.
Hepat Med
October 2023
Yale Liver Center and Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT, USA.
The COVID-19 pandemic has had a profound impact on global health, necessitating a comprehensive understanding of its diverse manifestations. Cholangiopathy, a condition characterized by biliary dysfunction, has emerged as a significant complication in COVID-19 patients. In this review, we report the epidemiology of COVID-19, describe the hepatotropism of SARS-CoV-2, and present the histopathology of acute liver injury (ALI) in COVID-19.
View Article and Find Full Text PDFPost-COVID-19 cholangiopathy: Systematic review.
World J Methodol
September 2023
Acute Medicine, University of South Wales, Cardiff CF37 1DL, United Kingdom.
Background: The coronavirus disease 2019 (COVID-19) pandemic has had a profound impact on global health, primarily characterized by severe respiratory illness. However, emerging evidence suggests that COVID-19 can also lead to secondary sclerosing cholangitis (SC), referred to as post-COVID-19 cholangiopathy.
Aim: To synthesize currently reported cases to assess the current state of knowledge on post-COVID-19 cholangiopathy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!